All Stories

  1. Outcomes from the International Society of Nephrology forum on complement therapeutics in C3 glomerulopathy and IgA nephropathy
  2. Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
  3. Indian Nephrologists’ Approaches to Shared Decision-Making, Advance Care Planning, and Palliative Care
  4. WCN26-5982 RANDOMIZED EMBEDDED ADAPTIVE PLATFORM CLINICAL TRIAL IN SOUTH ASIAN KIDNEY BIOPSY-PROVEN PRIMARY GLOMERULAR DISEASES: MULTI-CENTER, MULTI-ARM AND MULTI-STAGE- THE STORY SO FAR
  5. WCN26-2300 CENTRAL VENOUS ACCESS CARE PRACTICES IN HEMODIALYSIS CENTRES ACROSS INDIA-A CROSS SECTIONAL ANALYSIS
  6. WCN26-3316 IMPACT OF SUPPORTING EMERGING NEPHROLOGY CENTRE WITHIN THE SAME COUNTRY THROUGH THE ISN-SRC PROGRAMME
  7. WCN26-4120 Decoding the Genetic Landscape of Chronic Kidney Disease: Insights from a Prospective Indian CohortFunding
  8. WCN26-4246 Gut Microbiome in IgA Nephropathy: Associations with Baseline Disease Presentation and Longitudinal Clinical Outcomes in South Asians
  9. WCN26-5397 TREATMENT OUTCOMES AND ALLOGRAFT SURVIVAL IN KIDNEY TRANSPLANT RECIPIENT WITH TERTIARY HYPERPARATHYROIDISM: A SINGLE CENTER RETROSPECTIVE OBSERVATIONAL STUDY
  10. WCN26-6329 A COHORT STUDY ON THE BURDEN, DEMOGRAPHY, CLINICAL FEATURES AND SPECTRUM OF CHRONIC KIDNEY DISEASE IN THE RURAL AGRARIAN POPULATION OF INDIA WITH EMPHASIS ON CKDu
  11. WCN26-7555 Silent Invaders - A case series of CRBSI caused by Non-Tuberculous Mycobacteria in Hemodialysis patients
  12. WCN26-9313 PODOCYTE MACROPHAGE TRANSDIFFERENTIATION - ELECTRON MICROSCOPIC OBSERVATIONS IN TWO DISTINCT CLINICAL SETTINGS
  13. A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
  14. Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
  15. Baseline and longitudinal associations between serum C3/C4 levels, tissue complement biomarkers, and IgA nephropathy in South Asians
  16. Transplant Outcomes and Weight Management in Renal Disease Study
  17. A rare case of co-occurrence of lupus nephritis and lymphoma
  18. POS0974 TREATMENT RESPONSE AND LONG TERM OUTCOMES IN PURE MEMBRANOUS LUPUS NEPHRITIS: EMPHASIZING THE EFFECT OF HYPOALBUMINEMIA ON MYCOPHENOLIC ACID
  19. Clinical Profile and Outcomes of Thrombotic Microangiopathy: A Kidney Biopsy Registry Cohort
  20. Dematiaceous Fungal Infections in Kidney Transplant Recipients – Case Series
  21. Melioidosis in kidney transplant recipients: A report of two cases
  22. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Anemia in Chronic Kidney Disease: Guidelines for South Asia
  23. Retrospective Analysis of the Outcomes of Mycophenolate Therapy in Retarding the Progression of Immunoglobulin A Nephropathy (REMISSION IgA)
  24. Atrasentan in Patients with IgA Nephropathy
  25. WCN25-2452 FIBRIN SHEATH STRIPPING IN TUNNELED DIALYSIS CATHETERS: IS IT WORTH TRYING?
  26. WCN25-2458 RENAL BIOPSY BLEED: THE UNTOLD STORY
  27. WCN25-2779 EXPLORING PAEDIATRIC RENAL TRANSPLANTATION OUTCOMES IN THE MODERN ERA OF IMMUNOSUPPRESSION: A 17-YEAR SINGLE-CENTER EXPERIENCE
  28. WCN25-3334 EXPLORING THE BMD-TBS-BSI PARADOX IN PATIENTS WITH END-STAGE KIDNEY DISEASE – AT BASELINE, ACROSS THE TRANSPLANT TRANSITION AND BEYOND: A PROSPECTIVE STUDY
  29. WCN25-3498 Wrist Tenosynovitis and spina ventosa (tubercular dactylitis) due to Tuberculous and Non-Tuberculous Mycobacterial infections in Renal Transplant Recipients
  30. WCN25-3629 CLINICAL PROFILE, TREATMENT MODALITIES AND OUTCOME IN ANCA (ANTINEUTOPHILIC CYTOPLASMIC ANTIBODY) ASSOCIATED) VASCULITIS WITH KIDNEY INVOLVEMENT- A SINGLE CENTRE EXPERIENCE FROM SOUTH INDIA
  31. WCN25-3803 Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage
  32. WCN25-3889 CLINICAL PROFILE OF RENAL ALLOGRAFT RECIPIENTS SWITCHED TO MTOR INHIBITOR-BASED REGIMEN FROM TACROLIMUS AND MYCOPHENOLATE BASED REGIMENS: A SINGLE-CENTER RETROSPECTIVE OBSERVATIONAL STUDY
  33. WCN25-4104 BK Polyomavirus-Associated Urothelial Carcinoma of the Bladder in Kidney Transplant Recipients – a retrospective look over a 50 year period
  34. WCN25-4202 NAVIGATING THE THERAPEUTIC LANDSCAPE: A RETROSPECTIVE EXPLORATION OF TREATMENT OUTCOMES IN PRIMARY MEMBRANOUS NEPHROPATHY
  35. WCN25-4210 MALE LUPUS NEPHRITIS: A COMPREHENSIVE ANALYSIS OF CLINICAL FEATURES, SEROLOGICAL MARKERS, AND TREATMENT OUTCOMES
  36. WCN25-4606 DIAGNOSTIC UTILITY AND CLINICAL IMPACT OF GENOMIC TESTING NI ADOLESCENT AND ADULT KIDNEY DISEASE PATIENTS WITH SUSPECTED MONOGENIC ETIOLOGY – A PRAGMATIC PROSPECTIVE OBSERVATIONAL COHORT STUDY
  37. Comprehensive evaluation of bone health among kidney transplant recipients – A prospective, single center, observational cohort study from India
  38. Rare Mycobacterial Infections in Kidney Transplant Recipients – Case Reports
  39. Maternal, Fetal, and Kidney Outcomes of Viable Pregnancies in Women with Underlying Kidney Disease: Experience from a Single Tertiary Care Center in India
  40. Hyperaldosteronism secondary to renal agenesis: An unusual cause for hypertension in pregnancy
  41. Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
  42.  Looking backward at the future of AKI: A retrospective cohort study on the clinic-pathological variables affecting renal recovery after acute kidney injury 
  43. Nocardiosis in Renal Allograft Recipients
  44. Clinicopathological Profile and Outcomes of Kidney Amyloidosis: A Single-Centre Retrospective Biopsy Registry Cohort Study
  45. BK Viremia in Kidney Transplantation
  46. The pathogenesis of IgA nephropathy and implications for treatment
  47. Post‐conference review of oral session 6 and short talk in the 17th international IgA nephropathy conference, Tokyo 2023
  48. Hemato-Renal Profile of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits
  49. Glomerulonephritis After Renal Transplatation in South Asia - Single Center Experience Over 5 Decades
  50. Concomitant Histological Features of Membranous Nephropathy and Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis
  51. Impact of Noncommunicable Diseases and Heat Stress on Estimated Glomerular Filtration Rate in Security Officers at a Tertiary Care Hospital in South India
  52. POS0164 ARTERIOSCLEROSIS AND CREATININE AT REPEAT RENAL BIOPSY CAN PREDICT THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH LUPUS NEPHRITIS: -A TEN-YEAR FOLLOW-UP DATA
  53. Capacity for the management of kidney failure in the International Society of Nephrology South Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
  54. Assessment of renal function in persons with motor complete spinal cord injury—cystatin C as an accurate single marker
  55. A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
  56. Renal Disease in the Tropics
  57. Challenges and Lessons Learnt Learned from Industry-Driven Multi-Centre Global Clinical Trials in IgA Nephropathy (IgAN): Site Investigators' Perspective
  58. Diagnostic Utility and Clinical Impact of Genomic Testing in Adolescent and Adult Kidney Disease Patients with Suspected Monogenic Etiology by Establishing an Integrated Kidney Genetics Service
  59. Elevated Inflammatory Biomarkers Are Risk Factors for Composite Outcome in South Asian IgA Nephropathy (IgAN)
  60. Elevated Serum Gd-IgA1/s.IgA Levels and Not Serum Gd-IgA1 Alone Is an Independent Risk Factor for Composite Outcome in South Asian IgA Nephropathy (IgAN)
  61. Relevance of Serum A Proliferation-Inducing Ligand (APRIL) as a Biomarker in South Asian Prospective Longitudinal Observational IgA Nephropathy Cohort (GRACE-IgANI)
  62. Practice of dialysis access interventional nephrology procedures in the Asia‐Pacific region: Getting lay of the land
  63. Hydroxychloroquine-Induced Phospholipidosis – A Forgotten Complication of a Common Drug
  64. Bacterial infection‐related glomerulonephritis in patients with diabetes
  65. Profile, Risk Factors, and Outcomes of Asymptomatic Bacteriuria in Kidney Transplant Recipients with Normal Pretransplant Genitourinary Tract: A Single-Center Experience
  66. #3176 STUDY OF UNUSUAL/RARE INFECTIONS IN RENAL TRANSPLANT RECIPIENTS
  67. Patterns of Renal Dysfunction and Profile of Kidney Biopsies in Hematopoietic Stem Cell Transplant Recipients
  68. The first ABO incompatible kidney transplantation without splenectomy in India – A review at 12 years
  69. Treating Parvovirus Triggered Refractory Hemolytic Anemia with Rituximab in Renal Transplant Recipients – A Report of Two Cases
  70. Whole and cortical kidney volume predict 5‐year post‐nephrectomy eGFR in Indian living kidney donors
  71. POS-126 BACTERIAL INFECTION RELATED GLOMERULONEPHRITIS IN PATIENTS WITH DIABETES MELLITUS
  72. P16.29: Clinical Profile and Outcomes of COVID 19 Among Renal Transplant Recipients Across Three Waves of SARS CoV2 Infection: A Multicenter Study From South India
  73. POS-103 Serum and Glomerular Complement Components as Biomarkers in the First South-Asian Prospective Longitudinal Observational IgA Nephropathy cohort (GRACE-IgANI)
  74. Impact of the lockdown on patients receiving maintenance hemodialysis at a tertiary care facility in Southern India – A mixed-methods approach
  75. Skin colonizers and catheter associated blood stream infections in incident Indian dialysis patients
  76. Three-Year Clinical Outcomes of the First South Asian Prospective Longitudinal Observational IgA Nephropathy Cohort
  77. International IgA Nephropathy Network (IIgANN) Risk Prediction and Longitudinal Outcomes in the First South-Asian Prospective IgA Nephropathy Cohort (GRACE-IgANI)
  78. Serum and Glomerular Complement Components as Biomarkers in the First South Asian Prospective Longitudinal Observational IgA Nephropathy Cohort (GRACE-IgANI)
  79. Peritoneal dialysis: Status report in South and South East Asia
  80. Bacterial infections and it's impact on kidneys
  81. Difficult cannulation of hemodialysis arteriovenous fistula – Role of imaging in access management (DICAF STUDY)
  82. Impact of National Economy and Policies on End-Stage Kidney Care in South Asia and Southeast Asia
  83. Interventional nephrology and vascular access practice: A perspective from South and Southeast Asia
  84. MO995DO THE TIMELINE AND SPECTRUM OF INFECTIONS CHANGE AFTER ANTI-REJECTION THERAPY IN KIDNEY TRANSPLANT RECIPIENTS?
  85. Safety and utility of kidney biopsy in patients with estimated glomerular filtration rate < 30 ml/min/1.73 m2
  86. POS-150 CLINICAL AND HISTOPATHOLOGICAL PROFILE AND OUTCOME OF PATIENTS WITH BIOPSY PROVEN PGNMID (PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IMMUNOGLOBULIN DEPOSITS)
  87. POS-687 DONOR CYSTATIN C eGFR> 100 ml/min/1.73m2 IS AN INDEPENDENT PREDICTOR OF GRAFT SURVIVAL IN INDIAN KIDNEY TRANSPLANT RECIPIENTS
  88. POS-743 EVALUATION OF GRAFT OUTCOMES IN RENAL TRANSPLANT RECIPIENTS IN A 10 YEAR PERIOD RANGING FROM 2008-2018 - A RETROSPECTIVE STUDY(REVERTER)
  89. POS-769 DOES EARLY ASYMPTOMATIC BACTERIURIA AFFECT GRAFT OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS FROM SOUTH ASIA?
  90. Epidemiology, baseline characteristics and risk of progression in the first South-Asian prospective longitudinal observational IgA nephropathy cohort
  91. Post‐transplant complications, patient, and graft survival in pediatric and adolescent kidney transplant recipients at a tropical tertiary care center across two immunosuppression eras
  92. Current Status and Future of End-Stage Kidney Disease in Gulf Cooperation Council Countries: Challenges and Opportunities
  93. Blind bedside peritoneal dialysis catheter repositioning: An innovative technique
  94. Does hemodialysis need to be initiated to improve platelet function in CKD G5 patients? A pilot prospective, observational cohort study
  95. Aetiology, practice patterns and burden of end‐stage kidney disease in South Asia and South‐East Asia: A questionnaire‐based survey
  96. Association of prior sensitizing events with anti-human leukocyte antigen antibodies: An analysis of renal transplant recipients in a tertiary care centre in South India
  97. Crescentic glomerulonephritis: what’s different in South Asia? A single center observational cohort study
  98. Crescentic Glomerulonephritis: What’s different in South Asia? - A Single Center Observational Cohort Study
  99. SAT-075 ASSESSMENT OF RENAL FUNCTION IN MOTOR COMPLETE SPINAL CORD INJURY PATIENTS – CYSTATIN C AS AN ACCURATE SINGLE MARKER
  100. SAT-376 TWO YEAR OUTCOME OF THE FIRST SOUTH ASIAN PROSPECTIVE LONGITUDINAL COHORT INVESTIGATING THE CLINICAL COURSE AND RISK PROFILE OF IGA NEPHROPATHY: GRACE IGANI COHORT
  101. SAT-377 BIOMARKER EVALUATION OF THE FIRST SOUTH ASIAN PROSPECTIVE LONGITUDINAL COHORT INVESTIGATING THE CLINICAL COURSE AND RISK PROFILE OF IGA NEPHROPATHY: GRACE IGANI COHORT
  102. SAT-378 De-novo and recurrent glomerulonephritis in renal allograft recipients – a single centre experience
  103. SUN-392 Crescentic Glomerulonephritis: A Single Center Observational Cohort Study On The Clinico-pathological Features And Follow-up Outcomes
  104. Effects of individualized dialysate sodium prescription in hemodialysis – Results from a prospective interventional trial
  105. Crystals, crystals everywhere but not a clue till late… Light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy
  106. MON-087 BEDSIDE PERITONEAL DIALYSIS CATHETER REPOSITIONING - A NOVEL TECHNIQUE
  107. Fast and furious: a retrospective study of catheter-associated bloodstream infections with internal jugular nontunneled hemodialysis catheters at a tropical center
  108. Utility of induction agents in living donor kidney transplantation
  109. Spectrum of biopsy proven renal disease in South Asian children: Two decades at a tropical tertiary care centre
  110. Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort
  111. Relationship of creatinine and cystatin c-based estimated glomerular filtration rates with measured glomerular filtration rate in healthy kidney donors from South Asia
  112. The long-term impact of hepatitis C infection in kidney transplantation in the pre-direct acting antiviral era
  113. Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?
  114. Gastric Glomus Tumour Misdiagnosed as Gastric Carcinoid: An Unfamiliar Entity with Aids to Diagnosis and Review of Literature
  115. Effect of double filtration plasmapheresis on various plasma components and patient safety: A prospective observational cohort study
  116. Comparison of Early Mechanical and Infective Complications in First Time Blind, Bedside, Midline Percutaneous Tenckhoff Catheter Insertion with Ultra-Short Break-in Period in Diabetics and Non-Diabetics: Setting New Standards
  117. Recurrent truncating mutations in alanine-glyoxylate aminotransferase gene in two South Indian families with primary hyperoxaluria type 1 causing later onset end-stage kidney disease
  118. Esophageal vasculitis in granulomatosis with polyangiitis
  119. Immunoglobulin G4-related tubulointerstitial nephritis associated with interstitial pulmonary disease: Report of a case with review of literature
  120. Impact of hepatitis B and C infections in renal transplantation
  121. Pharmacokinetics of Concentration-Controlled Mycophenolate Mofetil in Proliferative Lupus Nephritis
  122. Profile of incident chronic kidney disease related-mineral bone disorders in chronic kidney disease Stage 4 and 5: A hospital based cross-sectional survey
  123. First Case on Successful Management of Manganism With Renal Transplantation
  124. Posterior reversible encephalopathy syndrome in a renal allograft recipient: A complication of immunosuppression?
  125. Extensive emphysematous pyelonephritis in a renal allograft treated conservatively: case report and review of the literature
  126. Fenoldopam for preventing and treating acute kidney injury
  127. Percutaneous PD catheter insertion after past abdominal surgeries